Saxagliptin - PDFSEARCH.IO - Document Search Engine

Saxagliptin
Results: 87

#	Item
71	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Dermatologic and Ophthalmic Drugs Advisory Committee Center for Drug Evaluation and Research George Yancopoulos Regeneron Ketorolac Food and Drug Administration Pharmaceutical sciences Clinical research
72	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Clinical research Center for Drug Evaluation and Research Lorcaserin New Drug Application Food and Drug Administration Pharmaceutical sciences Pharmacology
73	Saxagliptin (Onglyza): A Case Study in Quality Risk Management Stephen Liebowitz, Ph.D. Group Director Global Regulatory Sciences Add to Reading List Source URL: www.fda.gov Language: English Dipeptidyl peptidase-4 inhibitors Alcohols Nitriles Bristol-Myers Squibb Saxagliptin Knowledge management Chemistry Organic chemistry Amides
74	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Medicine Pharmacology Benzazepines Lorcaserin Organochlorides Center for Drug Evaluation and Research Food and Drug Administration Pharmaceutical sciences Clinical research
75	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Anorectics Combination drugs Bupropion/naltrexone Pharmaceutical industry Center for Drug Evaluation and Research Bupropion Naltrexone New Drug Application Pharmacology Chemistry Medicine
76	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Biosimilar Biotechnology Drugs Dissolution testing Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research
77	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Drug safety Medicine Quality Quality by Design Food and Drug Administration United States Pharmacopeia Over-the-counter drug International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Monograph Pharmaceuticals policy Pharmacology Pharmaceutical sciences
78	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Health Pyrazines Telaprevir Food and Drug Administration Ribavirin Interferon Hepatitis Protease inhibitors Antivirals Pharmacology
79	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Alkenes Axitinib Benzamides Pyridines Thioethers New Drug Application Peginesatide Chemistry Food and Drug Administration Organic chemistry
80	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Clinical research Protease inhibitors Food and Drug Administration Ribavirin Triazoles Interferon Boceprevir Merck & Co. Telaprevir Pharmacology Antivirals Pharmaceutical sciences

UPDATE